|
Index of reports
> Cases with Pneumonia (246)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cyclophosphamide where reactions include pneumonia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 246 Next >>
Possible Cyclophosphamide side effects in 65 year old female
Reported by a physician from Japan on 2012-08-24
Patient: 65 year old female, weighing 50.2 kg (110.6 pounds)
Reactions: Weight Decreased, Blood Bilirubin Increased, Cytomegalovirus Viraemia, Headache, Pyrexia, Interstitial Lung Disease, Oedema, Thrombocytopenia, Blood Sodium Decreased, Decreased Appetite, Vomiting, Stomatitis, Pneumonia, Alanine Aminotransferase Increased, Lymphopenia, Anaemia, Febrile Neutropenia, Rash, Blood Phosphorus Decreased, Blood Potassium Decreased, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Adriamycin PFS
Dosage: 30 mg/m2 x 1/4 week
Start date: 2011-03-16
Adriamycin PFS
Dosage: 40 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Carboplatin
Dosage: 250 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Cyclophosphamide
Dosage: 350 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Etoposide
Dosage: 100 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Prednisolone
Dosage: 1mg/kg x 1/2 week
Start date: 2011-12-13
End date: 2011-12-14
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Start date: 2011-03-16
Prednisolone
Dosage: 2 mg/m2, 1x/day
Administration route: Oral
Start date: 2011-03-24
Ranimustine
Dosage: 60 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-16
Vincristine Sulfate
Dosage: 1 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Vindesine Sulfate
Dosage: 2.4 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Other drugs received by patient: Mucosolvan; Lansoprazole; Sulfamethoxazole and Trimethoprim; Armodafinil; Zolpidem; Olopatadine HCL; Cefazolin Sodium; Ciprofloxacin HCL; Armodafinil; Zovirax; Magmitt; Alendronate Sodium
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: male, weighing 103.1 kg (226.8 pounds)
Reactions: Plasmacytosis, Pneumonia, Mouth Haemorrhage, Pseudomonas Infection, Headache, Disease Progression, Death, Mucosal Inflammation, Pleural Effusion, Depressed Level of Consciousness, Abscess, Lethargy, RIB Fracture
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cisplatin
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Doxorubicin Hydrochloride
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Radiation Therapy NOS
Indication: Multiple Myeloma
Revlimid
Indication: Multiple Myeloma
Thalidomide
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Other drugs received by patient: Bendamustine Hydrochloride; Lenalidomide
Possible Cyclophosphamide side effects in
Reported by a physician from Netherlands on 2012-08-22
Patient:
Reactions: Pneumonia, Pain
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 4000 mg/m2, unk
Start date: 2012-02-03
End date: 2012-02-03
Cyclophosphamide
Dosage: 500 mg/m2, unk
Indication: Multiple Myeloma
Start date: 2011-12-23
End date: 2011-12-30
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-12-23
End date: 2012-01-03
Velcade
Dosage: 1.3 mg/m2, unk
Indication: Multiple Myeloma
Start date: 2011-12-23
End date: 2012-01-02
Other drugs received by patient: Tramal / 00599201 /; Acetaminophen; Ascal / 00002702 /; Oxycodone HCL; Fluconazole; Gabapentin; Persantine; Haldol; Omeprazole; Butrans; Fragmin; Esomeprazole Sodium; Pregabalin; Cotrim; Valaciclovir; Hydrochlorothiazide
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-22
Patient: male
Reactions: Pneumonia, Pancytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2011-09-20
End date: 2011-09-22
Fludarabine Phosphate
Start date: 2011-09-20
End date: 2011-09-22
Mabthera
Start date: 2011-09-20
End date: 2011-09-20
Other drugs received by patient: Bactrim DS; Valaciclovir
Possible Cyclophosphamide side effects in male
Reported by a physician from United States on 2012-08-22
Patient: male
Reactions: Rectal Haemorrhage, Constipation, Cardiac Disorder, Hospitalisation, Granulocytopenia, Inappropriate Antidiuretic Hormone Secretion, Thrombocytopenia, Cardiac Failure Congestive, Pneumonia, Anaemia, Pancytopenia, Atrial Fibrillation, Febrile Neutropenia, Syncope, Embolism, Sepsis, Dehydration, Asthenia, Mantle Cell Lymphoma Recurrent, Leukopenia, Deep Vein Thrombosis, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1
Indication: Mantle Cell Lymphoma
Cyclophosphamide
Dosage: on day 1
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: on day 1
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: on day 1
Indication: Mantle Cell Lymphoma
Leukine
Dosage: on day 9-15; 250 mcg/m2/day
Indication: Mantle Cell Lymphoma
Leukine
Dosage: on day 9-15; 250 mcg/m2/day
Indication: Diffuse Large B-Cell Lymphoma
Prednisone TAB
Dosage: on days 1-5
Indication: Mantle Cell Lymphoma
Prednisone TAB
Dosage: on days 1-5
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: on day 15; as infusion
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: on day 15; as infusion
Indication: Mantle Cell Lymphoma
Vincristine
Dosage: on day 1 (maximum dose: 2mg)
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: on day 1 (maximum dose: 2mg)
Indication: Mantle Cell Lymphoma
Possible Cyclophosphamide side effects in male
Reported by a consumer/non-health professional from Germany on 2012-08-21
Patient: male, weighing 86.0 kg (189.2 pounds)
Reactions: Pneumonia, Pulmonary Embolism, Cytomegalovirus Infection, Pulmonary Infarction, Lymphoma, Staphylococcal Sepsis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg, qd (day 1)
Indication: T-Cell Lymphoma
Start date: 2009-12-07
End date: 2010-01-11
Doxorubicin HCL
Dosage: 100 mg, qd (day 1)
Indication: T-Cell Lymphoma
Start date: 2009-12-07
End date: 2010-01-11
Filgrastim
Dosage: 48 unk, qd (day 1)
Indication: T-Cell Lymphoma
Start date: 2009-12-25
End date: 2010-01-15
Mabcampath
Dosage: 30 mg, day 4 and 5 of each cycle 1-3
Indication: T-Cell Lymphoma
Start date: 2009-12-10
End date: 2010-01-15
Prednisone
Dosage: 10 mg, qd (day 1-5)
Administration route: Oral
Indication: T-Cell Lymphoma
Start date: 2009-11-27
End date: 2010-01-10
Vincristine
Dosage: 1 mg, qd (day 1)
Indication: T-Cell Lymphoma
Start date: 2009-11-26
End date: 2010-01-11
Other drugs received by patient: Torsemide; Metoprolol Succinate; Heparin; Marcumar; Pantoprazole; Sulfamethoprim
Possible Cyclophosphamide side effects in male
Reported by a physician from Japan on 2012-08-18
Patient: male
Reactions: Drug Eruption, Pneumonia, Oral Candidiasis, Oral Herpes, Decreased Appetite
Adverse event resulted in: death
Drug(s) suspected as cause:
Actonel
Administration route: Oral
Start date: 2009-05-26
End date: 2011-10-15
Aspirin
Administration route: Oral
Start date: 2006-12-22
End date: 2011-10-15
Cyclophosphamide
Administration route: Oral
Start date: 2009-05-25
End date: 2011-10-15
Cyclophosphamide
Administration route: Oral
Indication: Idiopathic Pulmonary Fibrosis
Start date: 2006-12-22
End date: 2007-03-19
Cyclophosphamide
Administration route: Oral
Start date: 2008-08-18
End date: 2009-05-24
Cyclophosphamide
Administration route: Oral
Start date: 2007-03-20
End date: 2008-08-17
Mucodyne
Administration route: Oral
Indication: Idiopathic Pulmonary Fibrosis
Start date: 2007-04-17
End date: 2011-10-15
Mucosolvan
Administration route: Oral
Indication: Idiopathic Pulmonary Fibrosis
Start date: 2007-10-23
End date: 2011-10-15
Pirfenidone
Dosage: 400 mg/am, 400 mg/pm, 600 mg night
Administration route: Oral
Start date: 2009-12-14
End date: 2010-07-07
Pirfenidone
Dosage: 600 mg/am, 600 mg/pm, 400 mg night
Administration route: Oral
Start date: 2010-07-07
End date: 2011-10-11
Pirfenidone
Dosage: 200 mg/am, 200 mg/pm, 400 mg night
Administration route: Oral
Start date: 2009-11-30
End date: 2009-12-14
Pirfenidone
Administration route: Oral
Indication: Idiopathic Pulmonary Fibrosis
Start date: 2009-11-16
End date: 2009-11-30
Povidone Iodine
Start date: 2009-05-27
End date: 2011-10-15
Prednisolone
Administration route: Oral
Indication: Idiopathic Pulmonary Fibrosis
Start date: 2006-12-22
End date: 2011-10-12
Prednisolone
Sulfamethoxazole and Trimethoprim
Administration route: Oral
Start date: 2007-03-21
End date: 2011-10-15
Zolpidem
Administration route: Oral
Start date: 2007-01-23
End date: 2011-10-15
Other drugs received by patient: Neoral; Flomox; Miconazole; Gentamicin Sulfate; Valtrex; Propeto; Neoral; Arasena-A; Olopatadine HCL; Hibidil; Myser
Possible Cyclophosphamide side effects in male
Reported by a physician from Australia on 2012-08-14
Patient: male
Reactions: Pneumonia, Nervous System Disorder, Delirium, Fall
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 3.5714 milligram
Indication: Multiple Myeloma
Start date: 2012-05-18
End date: 2012-05-30
Dexamethasone
Dosage: 1.4286 milligram
Indication: Multiple Myeloma
Start date: 2012-05-18
End date: 2012-05-30
Prednisolone
Start date: 2012-05-14
End date: 2012-06-13
Thalomid
Dosage: 50 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-18
End date: 2012-05-30
Other drugs received by patient: Perindopril Erbumine; Coloxyl with Senna; Lamivudine; Amiodarone HCL; Magmin; Morphine; Bisoprolol; Lactulose; Ventolin; Fluticasone Propionate / Salmeterol; Midazolam; Enoxaparin Sodium; Spiriva; Allopurinol; Fentanyl; Aspirin; Moviprep; Acetaminophen
Possible Cyclophosphamide side effects in male
Reported by a individual with unspecified qualification from United States on 2012-08-13
Patient: male, weighing 73.0 kg (160.6 pounds)
Reactions: Pneumonia, Dyspnoea, Hypotension, Malnutrition, Pseudomonas Infection, Atrial Fibrillation, Pulmonary Embolism, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg
Doxorubicin Hydrochloride
Dosage: 75 mg
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 750mg
Vincristine Sulfate
Dosage: 1.5mg
Possible Cyclophosphamide side effects in
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-09
Patient:
Reactions: Dermatitis Allergic, Pneumonia, Angina Pectoris, Febrile Neutropenia, Cognitive Disorder, Hepatitis, Arrhythmia, Interstitial Lung Disease, Gastrointestinal Disorder, Progressive Multifocal Leukoencephalopathy, Cardiac Failure Congestive, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Prednisone TAB
Indication: Diffuse Large B-Cell Lymphoma
Radiotherapy
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-09
Patient: male
Reactions: Pneumonia, Pancytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2011-09-20
End date: 2011-09-22
Fludarabine Phosphate
Start date: 2011-09-20
End date: 2011-09-22
Mabthera
Start date: 2011-09-20
End date: 2011-09-20
Other drugs received by patient: Bactrim DS; Valaciclovir
Possible Cyclophosphamide side effects in 64 year old male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-08
Patient: 64 year old male
Reactions: Pneumonia, Neutropenia, Leukaemia Plasmacytic, Disease Progression
Adverse event resulted in: death
Drug(s) suspected as cause:
Bortezomib
Indication: Leukaemia Plasmacytic
Cyclophosphamide
Dosage: 1 g
Indication: Leukaemia Plasmacytic
Dexamethasone
Dosage: 40 mg
Dexamethasone
Dosage: 40 mg
Indication: Leukaemia Plasmacytic
Lenalidomide
Dosage: 25 mg
Indication: Leukaemia Plasmacytic
Possible Cyclophosphamide side effects in 74 year old female
Reported by a consumer/non-health professional from United Kingdom on 2012-08-03
Patient: 74 year old female
Reactions: Drug Eruption, Pneumonia, Neutropenic Sepsis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Administration route: Oral
Start date: 2012-06-01
End date: 2012-06-08
Cyclophosphamide
Administration route: Oral
End date: 2012-07-13
Dexamethasone
Administration route: Oral
End date: 2012-07-09
Dexamethasone
Administration route: Oral
Start date: 2012-06-01
End date: 2012-06-04
Revlimid
Administration route: Oral
End date: 2012-07-18
Revlimid
Administration route: Oral
Start date: 2012-06-01
End date: 2012-06-21
Other drugs received by patient: Allopurinol; Whole Blood
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03
Patient: male, weighing 98.0 kg (215.6 pounds)
Reactions: Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
ABT-263
Administration route: Oral
Start date: 2010-12-14
ABT-263
Administration route: Oral
Start date: 2010-11-18
End date: 2010-11-20
Cyclophosphamide
Start date: 2010-11-17
End date: 2010-11-19
Cyclophosphamide
Start date: 2011-01-11
Fludarabine Phosphate
Start date: 2010-11-17
End date: 2010-11-19
Fludarabine Phosphate
Start date: 2010-12-15
Rituximab
Start date: 2010-11-15
End date: 2010-11-16
Rituximab
Start date: 2010-12-15
Other drugs received by patient: Ondansetron; Ondansetron; Acetaminophen; Acetaminophen; Diphenhydramine HCL; Dozol; Ondansetron; Ondansetron; Ondansetron; Diphenhydramine HCL; Lorazepam; Ondansetron; Ondansetron; Acetaminophen; Acetaminophen; Pegfilgrastim; Allopurinol; Diphenhydramine HCL; Ranitidine; Dexamethasone Phosphate; Dexamethasone Phosphate; Pegfilgrastim; Candesartan Cilexetil; Fluconazole; Acetaminophen; Ranitidine; Albuterol Sulate; Acyclovir; Pegfilgrastim; Hydrocortisone; Prochlorperazine; Acetaminophen; Ranitidine; Aluminium Chloride; Ondansetron; Ondansetron; Diphenhydramine HCL; Diphenhydramine HCL; Ranitidine; Dexamethasone Phosphate; Bactrim; Loperamide HCL; Magnesium Hydroxide TAB; Atorvastatin Calcium
Possible Cyclophosphamide side effects in 66 year old male
Reported by a physician from Japan on 2012-07-20
Patient: 66 year old male
Reactions: Pneumonia, Interstitial Lung Disease
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Adriamycin PFS
Dosage: 40 mg/m2, unk
Start date: 2010-12-22
End date: 2010-12-22
Adriamycin PFS
Dosage: 30 mg/m2, unk
Start date: 2010-10-14
End date: 2010-10-14
Adriamycin PFS
Dosage: 30 mg/m2, unk
Start date: 2010-11-24
End date: 2010-11-24
Adriamycin PFS
Dosage: 30 mg/m2, unk
Start date: 2010-12-29
End date: 2010-12-29
Adriamycin PFS
Dosage: 40 mg/m2, unk
Start date: 2010-11-16
End date: 2010-11-16
Adriamycin PFS
Dosage: 40 mg/m2, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-07
End date: 2010-10-07
Allopurinol
Dosage: 100 mg, 3x/day
Administration route: Oral
Start date: 2011-07-05
End date: 2011-07-19
Allopurinol
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Hyperuricaemia
End date: 2011-01-20
Amlodipine
Dosage: 5 mg, 1x/day
Administration route: Oral
Indication: Hypertension
Start date: 2010-10-08
End date: 2011-02-17
Baraclude
Dosage: 0.5 mg, 1/2day
Administration route: Oral
Indication: Hepatitis B
Start date: 2010-06-29
End date: 2011-07-19
Carboplatin
Dosage: 250 mg/m2, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-26
End date: 2010-12-08
Cefazolin Sodium
Dosage: unk
Administration route: Oral
Indication: Proctitis
Start date: 2010-10-22
End date: 2011-02-17
Cyclophosphamide
Dosage: 350 mg/m2, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-07
End date: 2010-12-22
Cymerin
Dosage: 60 mg/m2, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-14
End date: 2010-12-29
Cytarabine
Dosage: 40 mg, daily
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-11-18
End date: 2010-11-18
Diflucan
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Antifungal Prophylaxis
End date: 2011-01-11
Diflucan
Dosage: unk
Start date: 2011-01-19
End date: 2011-01-28
Etoposide
Dosage: 100 mg/m2, 3x/day
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-26
End date: 2010-12-08
Fentanyl
Dosage: unk
Indication: Stomatitis
Start date: 2011-01-02
End date: 2011-01-19
Fildesin
Dosage: 2.4 mg/m2, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-26
End date: 2010-12-08
KW-0761
Dosage: 1 mg/kg, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-08
End date: 2010-12-21
Lansoprazole
Dosage: 15 mg, 1x/day
Administration route: Oral
Start date: 2011-05-26
End date: 2011-07-19
Lansoprazole
Dosage: 15 mg, 1x/day
Administration route: Oral
Indication: Gastrooesophageal Reflux Disease
End date: 2011-02-17
Lipidil
Dosage: 100 df, 1x/day
Administration route: Oral
Indication: Hyperlipidaemia
End date: 2011-01-26
Lyrica
Dosage: 75 mg, 1x/day
Administration route: Oral
Indication: Pain
Start date: 2011-06-29
End date: 2011-07-19
Magmitt
Dosage: unk
Administration route: Oral
Indication: Constipation
Start date: 2011-01-07
End date: 2011-01-10
Meropenem
Dosage: 0.5 g, 2x/day
Indication: Pneumonia
Start date: 2011-01-07
End date: 2011-01-24
Meropenem
Dosage: 1 g, 3x/day
Start date: 2011-07-04
End date: 2011-07-15
Methotrexate Sodium
Dosage: 15 mg, daily
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-11-18
End date: 2010-11-18
Oncovin
Dosage: 1 mg/m2, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-07
End date: 2010-12-22
Pantosin
Dosage: unk
Administration route: Oral
Indication: Constipation
Start date: 2011-01-07
End date: 2011-01-10
Prednisolone
Dosage: 40 mg/m2, unk
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-07
End date: 2010-12-29
Prednisolone
Dosage: 10 mg, daily
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-11-18
End date: 2010-11-18
Sulfamethoxazole and Trimethoprim
Dosage: 1 df, 1x/day
Administration route: Oral
Start date: 2011-07-15
Sulfamethoxazole and Trimethoprim
Dosage: 1 df, 1x/day
Administration route: Oral
Indication: Antifungal Prophylaxis
End date: 2011-01-28
Vancomycin
Dosage: 0.5 g, 2x/day
Start date: 2011-01-07
End date: 2011-01-17
Zovirax
Dosage: unk
Start date: 2011-06-30
End date: 2011-07-08
Zovirax
Dosage: 200 mg, 1x/day
Administration route: Oral
Indication: Prophylaxis
End date: 2011-01-28
Zovirax
Dosage: 200 mg, 1x/day
Administration route: Oral
Start date: 2011-07-12
End date: 2011-07-19
Other drugs received by patient: Vfend; Targocid; Slow-K; Ciprofloxacin HCL
Possible Cyclophosphamide side effects in
Reported by a physician from Italy on 2012-07-20
Patient:
Reactions: Pneumonia, Respiratory Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 75% reduced r-chop
Cyclophosphamide
Dosage: on day 2
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: 75% reduced r-chop
Doxorubicin HCL
Dosage: on day 2
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: 75% reduced r-chop
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: on days 1-5
Administration route: Oral
Rituximab
Dosage: on day 1
Rituximab
Dosage: 75% reduced r-chop
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: 75% reduced r-chop
Vincristine
Dosage: on day 2, upto a maximum dose of 2 mg
Indication: Diffuse Large B-Cell Lymphoma
Possible Cyclophosphamide side effects in female
Reported by a physician from France on 2012-07-18
Patient: female, weighing 40.0 kg (88.0 pounds)
Reactions: Pneumonia, General Physical Health Deterioration, Febrile Neutropenia, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Adriamycin PFS
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Istodax
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-12
Prednisone
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Vincristine
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Possible Cyclophosphamide side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient:
Reactions: Pneumonia, Nausea, Lymphopenia, Hyperglycaemia, Anaemia, Febrile Neutropenia, Constipation, Renal Failure, Neuropathy Peripheral, Fatigue, Diarrhoea, Embolism, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 500 milligram/sq. meter
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Revlimid
Dosage: 15 milligram
Administration route: Oral
Velcade
Dosage: 1.3 milligram/sq. meter
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 milligram/sq. meter
Possible Cyclophosphamide side effects in male
Reported by a physician from Japan on 2012-07-16
Patient: male
Reactions: Drug Eruption, Pneumonia, Oral Candidiasis, Oral Herpes, Decreased Appetite
Adverse event resulted in: death
Drug(s) suspected as cause:
Actonel
Administration route: Oral
Start date: 2009-05-26
Aspirin
Administration route: Oral
Start date: 2006-12-22
Cyclophosphamide
Administration route: Oral
Start date: 2009-05-25
Cyclophosphamide
Administration route: Oral
Indication: Idiopathic Pulmonary Fibrosis
Start date: 2006-12-22
End date: 2007-03-19
Cyclophosphamide
Administration route: Oral
Start date: 2008-08-18
End date: 2009-05-24
Cyclophosphamide
Administration route: Oral
Start date: 2007-03-20
End date: 2008-08-17
Mucodyne
Administration route: Oral
Start date: 2007-04-17
Mucosolvan
Administration route: Oral
Start date: 2007-10-23
Pirfenidone
Administration route: Oral
Start date: 2009-11-30
End date: 2009-12-14
Pirfenidone
Administration route: Oral
Start date: 2009-12-14
End date: 2010-07-07
Pirfenidone
Administration route: Oral
Indication: Idiopathic Pulmonary Fibrosis
Start date: 2009-11-16
End date: 2009-11-30
Pirfenidone
Administration route: Oral
Start date: 2010-07-07
Povidone Iodine
Start date: 2009-05-27
Prednisolone
Administration route: Oral
Indication: Idiopathic Pulmonary Fibrosis
Start date: 2006-12-22
End date: 2011-10-12
Prednisolone
Sulfamethoxazole and Trimethoprim
Administration route: Oral
Start date: 2007-03-21
Zolpidem
Administration route: Oral
Start date: 2007-01-23
Other drugs received by patient: Olopatadine HCL; Valtrex; Gentamicin Sulfate; Propeto; Miconazole; Neoral; Flomax; Hibidil; Arasena-A; Neoral
Possible Cyclophosphamide side effects in 65 year old female
Reported by a physician from Japan on 2012-07-16
Patient: 65 year old female, weighing 50.2 kg (110.6 pounds)
Reactions: Pneumonia, Interstitial Lung Disease
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 250 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Cyclophosphamide
Dosage: 350 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Doxorubicin Hydrochloride
Dosage: 30 mg/m2 x 1/4 week
Start date: 2011-03-16
Doxorubicin Hydrochloride
Dosage: 40 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Etopophos Preservative Free
Dosage: 100 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Prednisolone
Dosage: 2 mg/m2, 1x/day
Administration route: Oral
Start date: 2011-03-24
Prednisolone
Dosage: 1mg/kg x 1/2 week
Start date: 2011-12-13
End date: 2011-12-14
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Start date: 2011-03-16
Ranimustine
Dosage: 60 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-16
Vincristine Sulfate
Dosage: 1 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Vindesine Sulfate
Dosage: 2.4 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Other drugs received by patient: Sulfamethoxazole and Trimethoprim; Alendronate Sodium; Magmitt; Mucosolvan; Zovirax; Diflucan; Ciprofloxacin HCL; Olopatadine HCL; Cefazolin Sodium; Zolpidem; Diflucan; Lansoprazole
Possible Cyclophosphamide side effects in 68 year old female
Reported by a health professional (non-physician/pharmacist) from Sweden on 2012-07-13
Patient: 68 year old female
Reactions: Pneumonia, Fungal Infection, Paraneoplastic Pemphigus, Cytomegalovirus Infection, Neutropenia, Herpes Zoster
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: unk, 1 course
Indication: Chronic Lymphocytic Leukaemia Recurrent
Cyclophosphamide
Dosage: unk, 2nd course
Fludara
Dosage: unk, 1 course
Indication: Chronic Lymphocytic Leukaemia Recurrent
Fludara
Dosage: unk, 2 course
Mabcampath
Dosage: 30 mg, 3x/w
Indication: Paraneoplastic Pemphigus
Other drugs received by patient: Prednisone; Prednisone; Bendamustine Hydrochloride; Prednisone; Rituximab
Possible Cyclophosphamide side effects in 68 year old female
Reported by a health professional (non-physician/pharmacist) from Sweden on 2012-07-09
Patient: 68 year old female
Reactions: Pneumonia, Fungal Infection, Paraneoplastic Pemphigus, Cytomegalovirus Infection, Neutropenia, Herpes Zoster
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: unk, 2nd course
Cyclophosphamide
Dosage: unk, 1 course
Indication: Chronic Lymphocytic Leukaemia Recurrent
Fludara
Dosage: unk, 1 course
Indication: Chronic Lymphocytic Leukaemia Recurrent
Fludara
Dosage: unk, 2 course
Mabcampath
Dosage: 30 mg, 3x/w
Indication: Paraneoplastic Pemphigus
Start date: 2009-02-01
Other drugs received by patient: Prednisone; Prednisone; Bendamustine Hydrochloride; Prednisone; Rituximab
Possible Cyclophosphamide side effects in male
Reported by a lawyer from Denmark on 2012-07-09
Patient: male
Reactions: Pneumonia, Respiratory Failure, Septic Shock, Leukopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-07-14
Mabthera
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-07-14
Oncovin
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-07-14
Prednisolone
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-07-14
Possible Cyclophosphamide side effects in
Reported by a physician from Hungary on 2012-07-05
Patient:
Reactions: Pneumonia, Respiratory Failure
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Lymphoma
Doxorubicin HCL
Indication: Lymphoma
Prednisone TAB
Indication: Lymphoma
Vincristine
Indication: Lymphoma
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-05
Patient: male
Reactions: Pneumonia, Respiratory Failure, Septic Shock, Leukopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2011-07-14
Mabthera
Start date: 2011-07-14
Oncovin
Start date: 2011-07-14
Prednisolone
Start date: 2011-07-14
Possible Cyclophosphamide side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29
Patient: female
Reactions: Pneumonia
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: (100 mg/m2 on days 1-14, oral
Administration route: Oral
Indication: Breast Cancer
Doxorubicin HCL
Dosage: (30 mg/m2 on days 1 and 8, intravenous (not otherwise specified)
Indication: Breast Cancer
Fluorouracil
Dosage: (500mg/m2 on days 1 and 8, intravenous (not otherwise specified))
Indication: Breast Cancer
Possible Cyclophosphamide side effects in 58 year old male
Reported by a physician from Japan on 2012-06-27
Patient: 58 year old male, weighing 63.0 kg (138.6 pounds)
Reactions: Pneumonia, Bone Marrow Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Adriamycin PFS
Dosage: 80 mg, 1x/day
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2009-01-16
End date: 2009-01-16
Cyclophosphamide
Dosage: 1250 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2009-01-16
End date: 2009-01-16
Methotrexate Sodium
Dosage: 15 mg, weekly
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2009-01-16
End date: 2009-01-23
Prednisolone
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2009-01-16
End date: 2009-01-20
Prednisolone
Dosage: 20 mg, weekly
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2009-01-16
End date: 2009-01-23
Rituximab
Dosage: 600 mg, 1x/day
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2009-01-16
End date: 2009-01-16
Vincristine Sulfate
Dosage: 2 mg, 1x/day
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2009-01-16
End date: 2009-01-16
Other drugs received by patient: Neutrogin; Neutrogin
Possible Cyclophosphamide side effects in female
Reported by a physician from Italy on 2012-06-26
Patient: female
Reactions: Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Start date: 2012-04-12
End date: 2012-05-03
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma
Start date: 2012-04-12
End date: 2012-05-03
Vincristine
Indication: non-Hodgkin's Lymphoma
Start date: 2012-04-12
End date: 2012-05-03
Other drugs received by patient: Pantoprazole
Possible Cyclophosphamide side effects in
Reported by a individual with unspecified qualification from Taiwan, Province of China on 2012-06-25
Patient:
Reactions: Gastrointestinal Haemorrhage, Pneumonia, Hepatitis Acute, Urinary Tract Infection, Febrile Neutropenia, Herpes Zoster, Fungaemia, Bacteraemia, Anal Abscess, Hepatitis B, Cardiac Failure Congestive
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Epirubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Mabthera
Indication: Diffuse Large B-Cell Lymphoma
Prednisone TAB
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: 1.4 mg/m2 (maximum 2 mg)
Indication: Diffuse Large B-Cell Lymphoma
Possible Cyclophosphamide side effects in male
Reported by a individual with unspecified qualification from Netherlands on 2012-06-21
Patient: male, weighing 61.0 kg (134.2 pounds)
Reactions: Pneumonia, Pulmonary Embolism
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: most recent dose prior to sae 20/dec/2011
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-20
Doxorubicin HCL
Dosage: most recent dose prior to sae 20/dec/2012
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-20
Filgrastim
Dosage: most recent dose prior to sae 21/dec/2011
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-21
Mabthera
Dosage: most recent dose prior to sae 27/dec/2011
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-20
Prednisone
Dosage: most recent dose prior to sae 31/dec/2011
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-20
Vincristine
Dosage: most recent dose prior to sae 20/dec/2011
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-20
Other drugs received by patient: Oxazepam; Colchicine; Acetaminophen; Pantoprazole; Movicolon
Page 1 Next >>
|
